| Literature DB >> 32160774 |
Philip Roger Goody1, Felix Jansen1, Mohammed Rabiul Hosen1, Dominik Christmann1, Sven Thomas Niepmann1, Andreas Zietzer, Matti Adam2, Florian Bönner3, Sebastian Zimmer1, Georg Nickenig1.
Abstract
Aortic valve stenosis is the most prevalent heart valve disease worldwide. Although interventional treatment options have rapidly improved in recent years, symptomatic aortic valve stenosis is still associated with high morbidity and mortality. Calcific aortic valve stenosis is characterized by a progressive fibro-calcific remodeling and thickening of the aortic valve cusps, which subsequently leads to valve obstruction. The underlying pathophysiology is complex and involves endothelial dysfunction, immune cell infiltration, myofibroblastic and osteoblastic differentiation, and, subsequently, calcification. To date, no pharmacotherapy has been established to prevent aortic valve calcification. However, novel promising therapeutic targets have been recently identified. This review summarizes the current knowledge of pathomechanisms involved in aortic valve calcification and points out novel treatment strategies.Entities:
Keywords: aortic valve; aortic valve stenosis; calcification; heart valve disease; inflammation; valvular endothelial cells; valvular interstitial cells
Year: 2020 PMID: 32160774 DOI: 10.1161/ATVBAHA.119.313067
Source DB: PubMed Journal: Arterioscler Thromb Vasc Biol ISSN: 1079-5642 Impact factor: 8.311